Nova Mentis Life Stock Performance
| NMLSF Stock | USD 0.03 0 6.14% |
Nova Mentis holds a performance score of 9 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 6.18, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nova Mentis will likely underperform. Use Nova Mentis Life potential upside, as well as the relationship between the skewness and day median price , to analyze future returns on Nova Mentis Life.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nova Mentis Life are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Nova Mentis reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.1 M |
Nova |
Nova Mentis Relative Risk vs. Return Landscape
If you would invest 3.65 in Nova Mentis Life on September 3, 2024 and sell it today you would lose (1.05) from holding Nova Mentis Life or give up 28.77% of portfolio value over 90 days. Nova Mentis Life is currently producing 3.0785% returns and takes up 26.7993% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Nova, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Nova Mentis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Mentis' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nova Mentis Life, and traders can use it to determine the average amount a Nova Mentis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1149
| Best Portfolio | Best Equity | |||
| Good Returns | NMLSF | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 26.8 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.08 actual daily | 61 61% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 9 91% of assets perform better |
Based on monthly moving average Nova Mentis is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nova Mentis by adding it to a well-diversified portfolio.
Nova Mentis Fundamentals Growth
Nova Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nova Mentis, and Nova Mentis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nova Pink Sheet performance.
| Return On Equity | -0.89 | |||
| Return On Asset | -0.52 | |||
| Current Valuation | 5.46 M | |||
| Shares Outstanding | 143.47 M | |||
| Price To Book | 7.68 X | |||
| Price To Sales | 5,731 X | |||
| EBITDA | (2.93 M) | |||
| Cash And Equivalents | 634.36 K | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.95 M) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 881.16 K | |||
About Nova Mentis Performance
By analyzing Nova Mentis' fundamental ratios, stakeholders can gain valuable insights into Nova Mentis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nova Mentis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nova Mentis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. Nova Mentis is traded on OTC Exchange in the United States.Things to note about Nova Mentis Life performance evaluation
Checking the ongoing alerts about Nova Mentis for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nova Mentis Life help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nova Mentis Life is way too risky over 90 days horizon | |
| Nova Mentis Life has some characteristics of a very speculative penny stock | |
| Nova Mentis Life appears to be risky and price may revert if volatility continues | |
| Nova Mentis Life has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.68 M) with loss before overhead, payroll, taxes, and interest of (5.44 K). | |
| Nova Mentis Life has accumulated about 634.36 K in cash with (1.95 M) of positive cash flow from operations. |
- Analyzing Nova Mentis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nova Mentis' stock is overvalued or undervalued compared to its peers.
- Examining Nova Mentis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nova Mentis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nova Mentis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nova Mentis' pink sheet. These opinions can provide insight into Nova Mentis' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nova Pink Sheet analysis
When running Nova Mentis' price analysis, check to measure Nova Mentis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Mentis is operating at the current time. Most of Nova Mentis' value examination focuses on studying past and present price action to predict the probability of Nova Mentis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Mentis' price. Additionally, you may evaluate how the addition of Nova Mentis to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |